Skip to content

A clinical study of doorva tail application in anal canal for healing the fissure in ano

Open randomized controlled clinical trials to evaluate the efficacy of doorva taila gudapuran in management of parikartika with special reference to fissure in ano - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056484
Enrollment
84
Registered
2023-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K602- Anal fissure, unspecified

Interventions

None listed

Sponsors

Dr Sonal Suresh Kad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having Lakshana with Parikartika acute and chronic fissure in ano

Exclusion criteria

Exclusion criteria: 1 Severe immune compromised patients 2 Patients with uncontrolled systemic disease like diabetes 3 Patients having parikartika secondary to ulcerative colitis syphilis crohns disease tuberculosis will be excluded 4 Patient with known case of CA rectum will be exclude

Design outcomes

Primary

MeasureTime frame
1 To determine the efficacy of Doorva tail gudapuran in the management of parikartikaTimepoint: 4 weeks

Secondary

MeasureTime frame
1 To evaluate the efficacy of doorva tail gudapuran on the sign & symptom of parikartika 2 To compare the effect of doorva tail & yashtimadhu tailaTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Sunil Jadhav

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta

sjadhav21066@gmail.com9823279290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026